Clinical trial NCT06087458 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-03-01 → 2028-06-01 3. primary completion date: 2027-06-01 → 2027-10-01 4. masking: NONE → SINGLE
Clinical trial NCT07400679 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-09-18 → 2026-07-08 3. primary completion date: 2026-09-18 → 2026-07-02 4. enrollment: 54 → 48 participants
Clinical trial NCT06864585 updates: 1. status: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-09-15 → 2026-04-20 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07524855 updates: 1. completion date: 2028-04-30 → 2029-10-10 2. enrollment: 33 → 170 participants
Clinical trial NCT07554365 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-06-29 3. primary completion date: 2026-06-01 → 2026-06-29 4. enrollment: 24 → 25 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07422285: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT06482268 updates: 1. primary completion date: 2025-02-28 → 2027-12-28 2. collaborators removed: CiRA Foundation
Clinical trial NCT07596173 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-10-14 → 2026-09-16 3. primary completion date: 2026-10-14 → 2026-09-16 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07597473 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-05-08
Clinical trial NCT07242469: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Ceasing to be Substantial Shareholders - TCA Investments & Servco Pacific Inc. & Mark Fukunaga